Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 42

1.

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.

Raymond VM, Gray SW, Roychowdhury S, Joffe S, Chinnaiyan AM, Parsons DW, Plon SE; Clinical Sequencing Exploratory Research Consortium Tumor Working Group.

J Natl Cancer Inst. 2015 Nov 20;108(4). pii: djv351. doi: 10.1093/jnci/djv351. Print 2016 Apr.

2.

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.

Schrader KA, Cheng DT, Joseph V, Prasad M, Walsh M, Zehir A, Ni A, Thomas T, Benayed R, Ashraf A, Lincoln A, Arcila M, Stadler Z, Solit D, Hyman DM, Zhang L, Klimstra D, Ladanyi M, Offit K, Berger M, Robson M.

JAMA Oncol. 2016 Jan;2(1):104-11. doi: 10.1001/jamaoncol.2015.5208. Erratum in: JAMA Oncol. 2016 Feb;2(2):279. Hyman, David [corrected to Hyman, David M].

3.

Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics.

ACMG Board of Directors.

Genet Med. 2015 Jun;17(6):505-7. doi: 10.1038/gim.2015.41. Epub 2015 Mar 12.

PMID:
25764213
4.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

5.

ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.

ACMG Board of Directors.

Genet Med. 2015 Jan;17(1):68-9. doi: 10.1038/gim.2014.151. Epub 2014 Nov 13.

PMID:
25356965
7.

Tumor genome analysis includes germline genome: are we ready for surprises?

Catenacci DV, Amico AL, Nielsen SM, Geynisman DM, Rambo B, Carey GB, Gulden C, Fackenthal J, Marsh RD, Kindler HL, Olopade OI.

Int J Cancer. 2015 Apr 1;136(7):1559-67. doi: 10.1002/ijc.29128. Epub 2014 Aug 14.

8.

Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.

Parsons DW, Roy A, Plon SE, Roychowdhury S, Chinnaiyan AM.

J Clin Oncol. 2014 Jul 20;32(21):2203-5. doi: 10.1200/JCO.2013.54.8917. Epub 2014 Jun 23. No abstract available.

9.

Traditional roles in a non-traditional setting: genetic counseling in precision oncology.

Everett JN, Gustafson SL, Raymond VM.

J Genet Couns. 2014 Aug;23(4):655-60. doi: 10.1007/s10897-014-9698-3. Epub 2014 Mar 1.

10.

Genetic counseling for the next 25 years: Models for the future.

Kenen RH, Smith AC.

J Genet Couns. 1995 Jun;4(2):115-24. doi: 10.1007/BF01408634.

PMID:
24234309
11.

A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes.

Chang CQ, Yesupriya A, Rowell JL, Pimentel CB, Clyne M, Gwinn M, Khoury MJ, Wulf A, Schully SD.

Eur J Hum Genet. 2014 Mar;22(3):402-8. doi: 10.1038/ejhg.2013.161. Epub 2013 Jul 24.

12.

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG; American College of Medical Genetics and Genomics.

Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.

13.

Designing transformative clinical trials in the cancer genome era.

Sleijfer S, Bogaerts J, Siu LL.

J Clin Oncol. 2013 May 20;31(15):1834-41. doi: 10.1200/JCO.2012.45.3639. Epub 2013 Apr 15. Review.

PMID:
23589555
14.

Building a personalized medicine infrastructure at a major cancer center.

Meric-Bernstam F, Farhangfar C, Mendelsohn J, Mills GB.

J Clin Oncol. 2013 May 20;31(15):1849-57. doi: 10.1200/JCO.2012.45.3043. Epub 2013 Apr 15. Review.

15.

Existing and emerging technologies for tumor genomic profiling.

MacConaill LE.

J Clin Oncol. 2013 May 20;31(15):1815-24. doi: 10.1200/JCO.2012.46.5948. Epub 2013 Apr 15. Review.

16.

Key principles and clinical applications of "next-generation" DNA sequencing.

Rizzo JM, Buck MJ.

Cancer Prev Res (Phila). 2012 Jul;5(7):887-900. doi: 10.1158/1940-6207.CAPR-11-0432. Epub 2012 May 22. Review.

17.

Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers.

Park JH, Gail MH, Greene MH, Chatterjee N.

J Clin Oncol. 2012 Jun 10;30(17):2157-62. doi: 10.1200/JCO.2011.40.1943. Epub 2012 May 14.

18.

The genetic basis for cancer treatment decisions.

Dancey JE, Bedard PL, Onetto N, Hudson TJ.

Cell. 2012 Feb 3;148(3):409-20. doi: 10.1016/j.cell.2012.01.014. Review.

19.

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).

Lindström S, Schumacher FR, Cox D, Travis RC, Albanes D, Allen NE, Andriole G, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Crawford ED, Diver WR, Gaziano JM, Giles GG, Giovannucci E, Gonzalez CA, Henderson B, Hunter DJ, Johansson M, Kolonel LN, Ma J, Le Marchand L, Pala V, Stampfer M, Stram DO, Thun MJ, Tjonneland A, Trichopoulos D, Virtamo J, Weinstein SJ, Willett WC, Yeager M, Hayes RB, Severi G, Haiman CA, Chanock SJ, Kraft P.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):437-44. doi: 10.1158/1055-9965.EPI-11-1038. Epub 2012 Jan 11.

20.

Bioinformatics challenges for personalized medicine.

Fernald GH, Capriotti E, Daneshjou R, Karczewski KJ, Altman RB.

Bioinformatics. 2011 Jul 1;27(13):1741-8. doi: 10.1093/bioinformatics/btr295. Epub 2011 May 19. Erratum in: Bioinformatics. 2011 Aug 15;27(16):2323.

Supplemental Content

Support Center